Bought $800.00 of LLY

Medical research will accelerate significantly with AI, but at the end of the day, companies that possess the talent and infrastructure to execute clinical trials will capture massive upside. Eli Lilly has had strong financial years overall, and with more breakthroughs still ahead, I believe it remains undervalued.